SciDEX — Pathology

Understanding Entity Pages

This page aggregates everything SciDEX knows about Pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Wiki Pages (20)

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (5)

Source	Relation	Type	Str
Amyotrophic Lateral Sclerosis	associated_with	disease	0.90
network abnormalities	correlates_with	unknown	0.80
C9orf72 haploinsufficiency	associated_with	gene	0.70
DAM (Disease-Associated Microglia)	causes	cell_type	0.70
36745234	display unique susceptibility to	paper	0.60

Targeting Hypotheses (30)

Hypothesis	Score	Disease	Analysis
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate	0.785	-	Do β-amyloid plaques and neurofibrillary
PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifie	0.780	neurodegeneration	-
GBA1/GCase restoration to reduce alpha-synuclein pathology i	0.760	neurodegeneration	Test
C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD	0.720	neurodegeneration	Test Hypothesis Fixtures
SASP-Secreted MMP-9 from Senescent Microglia Generates Patho	0.718	als	What are the mechanisms by which microgl

Liquid-to-Solid Transition Pathology Reveals Granule Weak Po	0.712	neurodegeneration	What determines the specificity of RNA-p
TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Ca	0.703	neurodegeneration	What mechanisms underlie neuronal resist
ISR/eIF2α~P Overflow Represses Synaptic Protein Synthesis Do	0.683	alzheimers	-
Glial Neuroinflammatory Amplification by TDP-43 Pathology	0.680	neurodegeneration	What mechanisms underlie TDP-43's contri
m6A Hypermethylation of SNCA mRNA Stabilises Alpha-Synuclein	0.662	parkinson	m6A RNA Modification and Alpha-Synuclein
Vascular mural cell degeneration precedes and exacerbates pa	0.661	alzheimers	SEA-AD Single-Cell Analysis: Cell-Type V
Alpha-synuclein phosphorylation-dominated LLPS hijacks synap	0.657	parkinsons	-
LRRK2 Haploinsufficiency Traps Microglia in Senescence-Like	0.650	parkinsons	-
TBK1 Insufficiency in Alzheimer Microglia Drives a Senescenc	0.633	alzheimers	-
sex-divergent microglial activation states and X-linked immu	0.626	neurodegeneration	Sex-Specific Microglial States in Amyloi
Cell-state stratification is required to resolve Sex-Specifi	0.612	neurodegeneration	Sex-Specific Microglial States in Amyloi
Age-Accelerated miR-155 Upregulation Primes Nigral Microglia	0.610	neuroinflammation	How do regional, age, and sex-dependent
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Sex-Specific Microglial States in Amyloi
APOE4 lipid dysregulation and synaptic phagocytosis as early	0.604	neurodegeneration	AD Master Plan preregistration: APOE
CSF p-tau217 Normalization Reflects Amyloid-Driven Tau Patho	0.586	neurodegeneration	-
Structure-interacting small molecules that stabilize the APO	0.580	neuroscience	APOE4-driven lipid metabolism dysregulat
TDP-43 Co-pathology Subtype Identified Through Motor Neuron	0.564	neurodegeneration	Methodology challenge: dataset 'Allen Br
Physiological SCFAs may worsen alpha-synuclein pathology thr	0.550	neurodegeneration	Do physiological concentrations of SCFAs
AAV-mediated RGS6 re-expression in SNpc after pathology onse	0.530	neurodegeneration	Does RGS6 upregulation or D2 autorecepto
Neurodevelopmental Sex Differences in Thalamocortical GluN2B	0.526	neuroscience	GluN2B-Mediated Thalamocortical Control
Autophagy Enhancement via mTOR Inhibition for C9orf72 Dipept	0.490	neurodegeneration	Test
Isoform-Selective Hsp70 Targeting Overcomes Stoichiometric I	0.481	protein-folding	Can chaperone enhancement approaches ove
Necroptosis-cGAS Feedforward Loop Converts TDP-43 Pathology	0.460	neuroinflammation	How does chronic cGAS/STING activation d
Age-dependent downregulation of KPNA2 creates limbic neuron-	0.452	neurodegeneration	What mechanisms drive TDP-43 pathology s
DNA Damage Repair Dysfunction Creating TDP-43 Pathology Feed	0.430	neurodegeneration	How does APOE4 mechanistically increase

Mentioning Analyses (5)

Experiments (0)

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Experiment

Type

Disease

Score

Feasibility

Model

Status

Est. Cost

No experiments found

Pathology

Understanding Entity Pages

Wiki Pages (20)

Alpha-Synuclein Pathology

Tau Pathology Pathway in Frontotemporal Dementia

Granulovacuolar Bodies: Neuronal Defense Mechanism Against Tau Pathology

Tau Pathology

C9orf72→RNA/Dipeptide Repeat Pathology→ALS/FTD — Causal Chain

Outgoing (0)

Incoming (5)

Targeting Hypotheses (30)

Mentioning Analyses (5)

test debate

How can circuit-level neurodegeneration mechanisms be identified without complet

What mechanisms underlie TDP-43's contribution to cognitive impairment severity

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer'

Experiments (0)

Related Papers (0)

Debates (5)

The abstract identifies APOE4 association with increased TDP-43 pathology but th

TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leadi

AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-4

The debate transcript shows incomplete analysis where the Theorist reached maxim

test debate [TARGET_ARTIFACT type=experiment id=exp-123]

Related Research

Liquid-to-Solid Transition Pathology Reveals Granule Weak Points

TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Cascade in Motor Neuro

Glial Neuroinflammatory Amplification by TDP-43 Pathology

m6A Hypermethylation of SNCA mRNA Stabilises Alpha-Synuclein Transcript and Prom

Vascular mural cell degeneration precedes and exacerbates parenchymal pathology

sex-divergent microglial activation states and X-linked immune escape genes as p

Cell-state stratification is required to resolve Sex-Specific Microglial States

Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Dis

Perturbation-first validation should precede therapeutic claims for Sex-Specific

APOE4 lipid dysregulation and synaptic phagocytosis as early drivers of AD patho

Pathology

Understanding Entity Pages

Wiki Pages (20)

Alpha-Synuclein Pathology

Tau Pathology Pathway in Frontotemporal Dementia

Granulovacuolar Bodies: Neuronal Defense Mechanism Against Tau Pathology

Tau Pathology

C9orf72→RNA/Dipeptide Repeat Pathology→ALS/FTD — Causal Chain

Tau Pathology Alters Oligodendrocyte Gene Methylation in [Alzheimer's Disease](/diseases/alzheimers-disease)

Mechanism: Progranulin Loss and TDP-43 Pathology in FTD

TPIRC - Tau Pathology and Immunotherapy Research Center

PSP Astrocytic Pathology: Tufted Astrocytes Mechanism

Tau Pathology Pathway

MSA Glial Pathology — Detailed Comparison with Parkinson's Disease

Cholinergic Neurod Pathology

Astrocytic Pathology in Progressive Supranuclear Palsy

TDP-43 Pathology in Corticobasal Syndrome

Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD

Tau Pathology in Alzheimer's Disease

Oligodendrocyte Pathology in 4R-Tauopathies

Corticobasal Syndrome Tau Pathology

BIN1→Endosomal Dysfunction→Tau Pathology→AD Causal Chain

Tau Pathology Severity Assessment Model — Braak Staging and Disease Progression

Outgoing (0)

Incoming (5)

Targeting Hypotheses (30)

Mentioning Analyses (5)

test debate

How can circuit-level neurodegeneration mechanisms be identified without complet

What mechanisms underlie TDP-43's contribution to cognitive impairment severity

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer'

Experiments (0)

Related Papers (0)

Debates (5)

The abstract identifies APOE4 association with increased TDP-43 pathology but th

TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leadi

AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-4

The debate transcript shows incomplete analysis where the Theorist reached maxim

test debate [TARGET_ARTIFACT type=experiment id=exp-123]

Related Research

Liquid-to-Solid Transition Pathology Reveals Granule Weak Points

TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Cascade in Motor Neuro

Glial Neuroinflammatory Amplification by TDP-43 Pathology

m6A Hypermethylation of SNCA mRNA Stabilises Alpha-Synuclein Transcript and Prom

Vascular mural cell degeneration precedes and exacerbates parenchymal pathology

sex-divergent microglial activation states and X-linked immune escape genes as p

Cell-state stratification is required to resolve Sex-Specific Microglial States

Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Dis

Perturbation-first validation should precede therapeutic claims for Sex-Specific

APOE4 lipid dysregulation and synaptic phagocytosis as early drivers of AD patho